1. Home
  2. INDP vs NTRP Comparison

INDP vs NTRP Comparison

Compare INDP & NTRP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INDP
  • NTRP
  • Stock Information
  • Founded
  • INDP 2000
  • NTRP 1985
  • Country
  • INDP United States
  • NTRP United States
  • Employees
  • INDP N/A
  • NTRP N/A
  • Industry
  • INDP Biotechnology: Pharmaceutical Preparations
  • NTRP
  • Sector
  • INDP Health Care
  • NTRP
  • Exchange
  • INDP Nasdaq
  • NTRP NYSE
  • Market Cap
  • INDP 8.8M
  • NTRP 8.8M
  • IPO Year
  • INDP N/A
  • NTRP N/A
  • Fundamental
  • Price
  • INDP $0.80
  • NTRP $4.29
  • Analyst Decision
  • INDP Strong Buy
  • NTRP Hold
  • Analyst Count
  • INDP 2
  • NTRP 1
  • Target Price
  • INDP $8.50
  • NTRP $5.00
  • AVG Volume (30 Days)
  • INDP 28.5K
  • NTRP 30.1K
  • Earning Date
  • INDP 03-12-2025
  • NTRP 03-31-2025
  • Dividend Yield
  • INDP N/A
  • NTRP N/A
  • EPS Growth
  • INDP N/A
  • NTRP N/A
  • EPS
  • INDP N/A
  • NTRP N/A
  • Revenue
  • INDP N/A
  • NTRP $623,664.00
  • Revenue This Year
  • INDP N/A
  • NTRP $354.28
  • Revenue Next Year
  • INDP N/A
  • NTRP $536.37
  • P/E Ratio
  • INDP N/A
  • NTRP N/A
  • Revenue Growth
  • INDP N/A
  • NTRP 186.93
  • 52 Week Low
  • INDP $0.72
  • NTRP $1.39
  • 52 Week High
  • INDP $3.10
  • NTRP $8.50
  • Technical
  • Relative Strength Index (RSI)
  • INDP 44.62
  • NTRP 35.81
  • Support Level
  • INDP $0.72
  • NTRP $4.05
  • Resistance Level
  • INDP $0.81
  • NTRP $5.00
  • Average True Range (ATR)
  • INDP 0.07
  • NTRP 0.82
  • MACD
  • INDP -0.00
  • NTRP -0.26
  • Stochastic Oscillator
  • INDP 34.43
  • NTRP 7.78

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's pre-clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

About NTRP NEXTTRIP INC

NextTrip Inc is a technology-driven platform delivering travel booking and travel media solutions. It provides individual and group travelers with vacations to popular and sought-after destinations in Mexico, the Caribbean, and across the world. NextTrip Media platform - Travel Magazine offers a social media platform for viewers to explore, educate, and share with friends their bucket list travel. The company is also launching an end-to-end content ecosystem that uses AI-assisted travel planning capturing advertising, building brand awareness, rewarding loyalty, and driving bookings.

Share on Social Networks: